A Welch’s two-sample t-test demonstrated that patients with metastatic disease at diagnosis had significantly higher Ki-67 indices (mean: 39.4%) compared to non-metastatic patients (mean: 21.6%) (p = 0.014). Here, MKI67 is linked to metastatic neoplasm.